Results 1 to 10 of about 284,151 (314)
A rare case of hepatoid adenocarcinoma of the lung [PDF]
The Clinical Respiratory Journal, 2023 Hepatoid adenocarcinoma of the lung is a special type of primary origin in the lung with obvious pathological features and short survival time. However, standard treatment guidelines have not yet been established.
Xuejian Sun +4 more
doaj +2 more sources
Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights from a comprehensive analysis [PDF]
BMC CancerBackground Hepatoid adenocarcinoma of the lung (HAL) is a distinctly uncommon subtype of lung adenocarcinoma (LAC), characterized by hepatoid features and an alarmingly low 5-year survival rate of approximately 8%.
Huijing Deng +4 more
doaj +2 more sources
Rare case of primary hepatoid adenocarcinoma of the lung
Сибирский онкологический журнал, 2022 Hepatoid adenocarcinoma is a rare type of adenocarcinoma with hepatocellular differention, which is characterized by early metastatic spread and poor prognosis. The treatment strategy in not clearly defined due to an extreme rarity of the tumor.
E. A. Toneev +3 more
doaj +1 more source
Acta Biochimica et Biophysica Sinica, 2023 The clinical oncogenic functions and mechanisms of activating transcription factor 1 (ATF1) in the progression of lung adenocarcinoma have not been completely elucidated.
Mei Jinhong +8 more
doaj +1 more source
Health Science Reports, 2023 Background Non‐small cell lung cancer (NSCLC) accounts for 85% of lung cancer cases, with smoking being a critical risk factor. The identification of NSCLC patients harboring epidermal growth factor receptor (EGFR) mutations, sensitized to tyrosine ...
Seyedeh Yasamin Parvar +5 more
doaj +1 more source
Expression of MAD2L1 in Lung Adenocarcinoma and Its Effect on Immune Microenvironment
Zhongliu Fangzhi Yanjiu, 2022 Objective To investigate the expression of MAD2L1 in lung adenocarcinoma and its effect on the prognosis and immune microenvironment of patients. Methods The difference of MAD2L1 expression in lung adenocarcinoma tissue and normal lung tissue was ...
LIU Yingbo +3 more
doaj +1 more source
International Journal of Medical Students, 2020 Background: Lymphatic spread of breast cancer is currently well understood and can be assessed in breast cancer patients through the use of lymphatic mapping with sentinel node biopsy, CT, PET. The Case: Here we present a case report of a 73-year-old
Rina Won Lee, Emily Denney
doaj +1 more source
High GNG4 expression is associated with poor prognosis in patients with lung adenocarcinoma
Thoracic Cancer, 2022 Background The purpose of this study was to explore the reason for guanine nucleotide binding‐protein gamma subunit‐4 (GNG4) overexpression and the relationship between GNG4 overexpression and the poor prognosis of lung adenocarcinoma (LUAD) patients ...
Bodong Zhou +7 more
doaj +1 more source
Frontiers in Oncology, 2022 BackgroundThe main aim of the study was to determine the risk factors of lung adenocarcinoma and to analyze the variations in the incidence of lung adenocarcinoma according to time, sex, and smoking status in North China.MethodsPatients with lung cancer ...
Daojuan Li +5 more
doaj +1 more source
World Journal of Surgical Oncology, 2022 Background Lung adenocarcinoma is the leading cause of cancer death worldwide. Recently, ubiquitin C-terminal hydrolase L1 (UCHL1) has been demonstrated to be highly expressed in many tumors and plays the role of an oncogene.
Jianbo Yao +9 more
doaj +1 more source